The Cost of the National Health Service in England and Wales.Brian Abel-Smith , R. M. Titmuss

1957 ◽  
Vol 62 (4) ◽  
pp. 439-440
Author(s):  
Michael M. Davis
BMJ ◽  
1980 ◽  
Vol 280 (6229) ◽  
pp. 1449-1449
Author(s):  
A. Smith

BMJ ◽  
1980 ◽  
Vol 280 (6230) ◽  
pp. 1535-1535
Author(s):  
P V Scott

Econometrica ◽  
1957 ◽  
Vol 25 (2) ◽  
pp. 372
Author(s):  
Jerome Rothenberg ◽  
Brian Abel-Smith ◽  
R. M. Titmuss

2018 ◽  
Vol 132 (12) ◽  
pp. 1119-1127 ◽  
Author(s):  
J F Guest ◽  
K Rana ◽  
C Hopkins

AbstractObjectiveThis study aimed to estimate the cost-effectiveness of Coblation compared with cold steel tonsillectomy in adult and paediatric patients in the UK.MethodDecision analysis was undertaken by combining published clinical outcomes with resource utilisation estimates derived from a panel of clinicians.ResultsUsing a cold steel procedure instead of Coblation is expected to generate an incremental cost of more than £2000 for each additional avoided haemorrhage, and the probability of cold steel being cost-effective was approximately 0.50. Therefore, the cost-effectiveness of the two techniques was comparable. When the published clinical outcomes were replaced with clinicians’ estimates of current practice, Coblation was found to improve outcome for less cost, and the probability of Coblation being cost-effective was at least 0.70.ConclusionA best-case scenario suggests Coblation affords the National Health Service a cost-effective intervention for tonsillectomy in adult and paediatric patients compared with cold steel procedures. A worst-case scenario suggests Coblation affords the National Health Service an equivalent cost-effective intervention for adult and paediatric patients.


2019 ◽  
Vol 4 (1) ◽  
pp. e000278 ◽  
Author(s):  
Hannah Forbes ◽  
Matt Sutton ◽  
David F Edgar ◽  
John Lawrenson ◽  
Anne Fiona Spencer ◽  
...  

ObjectivesGlaucoma filtering schemes such as the Manchester Glaucoma Enhanced Referral Scheme (GERS) aim to reduce the number of false positive cases referred to Hospital Eye Services. Such schemes can also have wider system benefits, as they may reduce waiting times for other patients. However, previous studies of the cost consequences and wider system benefits of glaucoma filtering schemes are inconclusive. We investigate the cost consequences of the Manchester GERS.DesignObservational study.MethodsA cost analysis from the perspective of the National Health Service (NHS) was conducted using audit data from the Manchester GERS.Results2405 patients passed through the Manchester GERS from April 2013 to November 2016. 53.3% were not referred on to Manchester Royal Eye Hospital (MREH). Assuming an average of 2.3 outpatient visits to MREH were avoided for each filtered patient, the scheme saved the NHS approximately £2.76 per patient passing through the scheme.ConclusionOur results indicate that glaucoma filtering schemes have the potential to reduce false positive referrals and costs to the NHS.


BMJ ◽  
1980 ◽  
Vol 280 (6230) ◽  
pp. 1535-1536
Author(s):  
N H Harris

2014 ◽  
Vol 27 (1) ◽  
pp. 92 ◽  
Author(s):  
Ana Moutinho ◽  
Denise Alexandra ◽  
Renata Rodrigues

<strong>Introduction:</strong> In order to cut spending, compulsory INN prescription was suggested in Portugal during 2012. This instigated discussion among stakeholders in the matter. The authors studied prescription-dispensing dynamics in a real population.<br /><strong>Objectives:</strong> To determine the percentage of swapped prescriptions; to assess factors associated with the swap; to analyse justifications for doing so; to quantify the cost difference for patients and the National Health Service.<br /><strong>Material and Methods:</strong> Analytic study. Convenience sample consisting of all prescriptions from a Primary Health Care unit, from the 19th to the 23rd December 2011. Third day follow-up, using phone call interviews. Software: Excel and SPSS. Tests: Chi-square and Mann-Whitney, SL = 0.05.<br /><strong>Results:</strong> Total of 255 prescriptions. Majority prescribed to women (62%), mean age of 52, four years of school education and for acute situations. A percentage of 31% of prescribed drugs were swapped. The swaps had no statistical relation with age, sex or literacy of the patient, nor with the prescriber or pharmacy. Swapping of prescribed drugs for chronic situations was lower (p &lt; 0.001), as well as for original brand prescriptions (p &lt; 0.001). Anti-infectious and anti-allergic were the most swapped groups (p = 0.009). Seventy-two percent of users were not aware of the swap. Regarding the swapped drugs, users paid on average 79% more than what was originally prescribed, and the National Health Service 5% more.<br /><strong>Discussion/Conclusion:</strong> The authors found changes in 31% of the prescriptions, with higher costs for both users and National Health Service. Selection, information and registration bias were considered. With compulsory INN prescriptions, we suggest regular analysis of prescription-dispensing dynamics, based on the available national data.


Sign in / Sign up

Export Citation Format

Share Document